Lifecore Biomedical, Inc. · NASDAQ:LFCR
Nelson Obus reported a 14.30% stake in Lifecore Biomedical, Inc. (Schedule 13D/A)
Event Sep 27, 2026 · Filed Sep 29, 2026
Nelson Obus reported a 14.30% stake in Lifecore Biomedical, Inc., 5,512,210 shares, with active intent on Sep 27, 2026. Filed Sep 29, 2026 (Schedule 13D/A).
- Stake
- 14.30%
- Shares
- 5,512,210
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 8 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Wynnefield Partners Small Cap Value, L.P. I | 6.30% | 2,405,090 |
| Wynnefield Partners Small Cap Value, L.P. | 4.10% | 1,551,295 |
| Wynnefield Small Cap Value Offshore Fund, Ltd. | 2.70% | 1,024,376 |
| Wynnefield Capital, Inc. Profit Sharing & Money Purchase Plan | 1.00% | 367,350 |
| Wynnefield Capital Management, LLC | 10.30% | 3,956,385 |
| Wynnefield Capital, Inc. | 2.70% | 1,024,376 |
| Nelson Obus | 14.30% | 5,512,210 |
| Joshua Landes | 13.90% | 5,348,110 |
Source
Related
- Lifecore Biomedical, Inc.
- Nelson Obus
- Lifecore Biomedical, Inc. shareholders
- Schedule 13D/A · Legion Partners Asset Management, LLC · Sep 28, 2026
- Schedule 13G · BlackRock, Inc. · Jul 29, 2026
- Schedule 13D/A · Legion Partners Asset Management, LLC · Jul 2, 2026
- Schedule 13D/A · 22NW Fund, LP · Jul 2, 2026
- Form 4 · Legion Partners, L.P. I · Jun 8, 2026